Michael A. Berman - 01 Aug 2022 Form 4 Insider Report for M.D.C. HOLDINGS, INC.

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
03 Aug 2022, 10:18:48 UTC
Prior SEC filing
03 Aug 2021
Next SEC filing
14 Jun 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Michael A. Berman

Key filing fact

Michael A. Berman filed Form 4 for M.D.C. HOLDINGS, INC. on 03 Aug 2022.

Key facts

  • This page summarizes Michael A. Berman's Form 4 filing for M.D.C. HOLDINGS, INC..
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 03 Aug 2022, 10:18.

Change

  • Previous filing in this sequence was filed on 03 Aug 2021.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MDC transaction

Common Stock $.01 Par Value

Award

Transaction value
$0
Shares
+4,556
Change %
+17%
Price
$0.000000
Shares after
31,585
Date
01 Aug 2022
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MDC transaction Derivative

Non-Statutory Stock Option (right to buy)

Award

Transaction value
$0
Shares
+15,000
Change %
Price
$0.000000
Shares after
15,000
Date
01 Aug 2022
Ownership
Direct
Underlying class
Common Stock $ .01 Par Value
Underlying amount
15,000
Exercise price
$36.48
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Shares of restricted stock awarded on August 1, 2022 for no cash consideration pursuant to the Company's 2020 Equity Plan for Non-Employee Directors and a Restricted Stock Award Agreement. Pursuant to the Restricted Stock Award Agreement, the restrictions will lapse on the date that is seven months after the grant date.

Footnote F2

Represents a stock option under the Company's 2020 Stock Option Plan for Non-Employee Directors, which meets all of the requirements under Rule 16b-3.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .